Axogen, Inc. — Director's Dealing 2017

Dec 14, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AxoGen, Inc. (AXGN)
CIK: 0000805928
Period of Report: 2017-12-11

Reporting Person: Grooms Jamie Mark (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-12-11	Common Stock	S	21820	$26.35	Disposed	257192	Direct
2017-12-12	Common Stock	S	16585	$26.34	Disposed	240607	Direct

Footnotes

F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 20, 2017 (the "Plan"). All shares pursuant to the Plan have been sold as of the last sales reported herein.

F2: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.05 to $26.65. The reporting person undertakes to provide to AxoGen, Inc., any security holder of AxoGen, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

F3: These shares of common stock include 108,883 shares held by the Jamie Grooms Trust, of which Mr. Grooms is the trustee.

F4: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.10 to $26.90. The reporting person undertakes to provide to AxoGen, Inc., any security holder of AxoGen, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

F5: These shares of common stock include 107,883 shares held by the Jamie Grooms Trust, of which Mr. Grooms is the trustee.